Concepedia

Vasiliki Kossyvaki

VK

Statistics

Publications

3

Citations

53

H-Index

3

Active since

2022

Affiliations

Pfizer (United States)(Current)

Vasiliki Kossyvaki is an author at Pfizer (United States).

Publications per year

2022–2023

3

Publications

3

Estimating the Clinical and Economic Impact of Switching from the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) to Higher-Valent Options in Greek Infants

Sophie Warren, Myrto Barmpouni, Vasiliki Kossyvaki et al. · Vaccines · 2023 · 24 citations · Full text

Health and economic outcomes of 20-valent pneumococcal conjugate vaccine compared to 15-valent pneumococcal conjugate vaccine strategies for adults in Greece

George Gourzoulidis, Myrto Barmpouni, Vasiliki Kossyvaki et al. · Frontiers in Public Health · 2023 · 16 citations · Full text

Pneumococcal serotypes in adults hospitalized with community-acquired pneumonia in Greece using urinary antigen detection tests: the EGNATIA study, November 2017 – April 2019

Adamantia Liapikou, Athanasios Konstantinidis, Vasiliki Kossyvaki et al. · Human Vaccines & Immunotherapeutics · 2022 · 13 citations · Full text

1–3 of 3